Metformin and the Liver: Unlocking the Full Therapeutic Potential
Metabolites · 25.03.2024 · 14 (4) · 186
DOI: 10.3390/metabo14040186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 25.03.2024. Verfasst von Federica Perazza und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metformin is a highly effective medication for managing type 2 diabetes mellitus. Recent studies have shown that it has significant therapeutic benefits in various organ systems, particularly the liver. Although the effects of metformin on metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis are still being debated, it has positive effects on cirrhosis and anti-tumoral properties, which can help prevent the development of hepatocellular carcinoma. Furthermore, it has been proven to improve insulin resistance and dyslipidaemia, commonly associated with liver diseases. While more studies are needed to fully determine the safety and effectiveness of metformin use in liver diseases, the results are highly promising. Indeed, metformin has a terrific potential for extending its full therapeutic properties beyond its traditional use in managing diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
- Doctorate School of Nutrition Science, University of Milan, 20122 Milan, Italy.
- Centro Hercolani S.r.l., 40123 Bologna, Italy.
- U.O. Diabetologia, Ospedale C. Magati, Scandiano, 42019 Reggio Emilia, Italy.
- S.C. Endocrinologia Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy.
- Division of Hepatobiliary and Immunoallergic Diseases, Department of Internal Medicine, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40138 Bologna, Italy.
ORCID-Profile: Giulio Marchesini, Maria Letizia Petroni, Federico Ravaioli
Zitieren
APA
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D'Avino, M., Agnelli, G., Nicastri, A., Rossetti, C., Sacilotto, F., Marchesini, G., Petroni, M. L., & Ravaioli, F. (2024). Metformin and the Liver: Unlocking the Full Therapeutic Potential. Metabolites, 14(4), 186. https://doi.org/10.3390/metabo14040186
Vancouver
Perazza F, Leoni L, Colosimo S, Musio A, Bocedi G, D'Avino M, et al. Metformin and the Liver: Unlocking the Full Therapeutic Potential. Metabolites. 2024;14(4):186. doi:10.3390/metabo14040186
BibTeX
@article{Perazza2024,
author = {Perazza, Federica and Leoni, Laura and Colosimo, Santo and Musio, Alessandra and Bocedi, Giulia and D'Avino, Michela and Agnelli, Giulio and Nicastri, Alba and Rossetti, Chiara and Sacilotto, Federica and Marchesini, Giulio and Petroni, Maria Letizia and Ravaioli, Federico},
title = {Metformin and the Liver: Unlocking the Full Therapeutic Potential},
journal = {Metabolites},
year = {2024},
volume = {14},
number = {4},
pages = {186},
doi = {10.3390/metabo14040186}
}
EUVIMED